Penicillamine-induced bullous dermatoses

Journal of the American Academy of Dermatology

Volumn 35, Issue 5 I, 1996, Pages 732-742

  Bialy Golan, Anat ^a   Brenner, Sarah ^a,b  

^a TEL AVIV UNIVERSITY   (Israel)

^b TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

HLA DR ANTIGEN; PENICILLAMINE; THIAZOLIDINE DERIVATIVE;

AUTOIMMUNITY; BLOOD TOXICITY; BULLOUS SKIN DISEASE; DRUG METABOLISM; EPIDERMOLYSIS BULLOSA ACQUISITA; GASTROINTESTINAL TOXICITY; HUMAN; LUNG TOXICITY; MUCOUS MEMBRANE PEMPHIGOID; NEPHROTOXICITY; PEMPHIGOID; PEMPHIGUS; PRIORITY JOURNAL; REVIEW; SIDE EFFECT;

EID: 0029860874     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0190-9622(96)90729-X     Document Type: Review

References (113)

1. Abraham EP, Chain E, Baker W, et al. Penicillamine, a characteristic degradation product of penicillin. Nature 1943;151:107-10.
2. Walshe JM. Penicillamine: a new oral therapy for Wilson's disease. Am J Med 1956;2:487-95.
3. Boulding JE, McGill MD, Baker RA. The treatment of metal poisoning with penicillamine. Lancet 1957;2: 985.
4. Dresner E, Trombly P. Chemical dissociation of rheumatoid factor in vitro and vivo [abstract]. Clin Res 1960;8: 16.
5. Jaffe IA. The effect of penicillamine in the laboratory parameters in rheumatoid arthritis. Arthritis Rheum 1965; 8:1064-79.
6. Day AT, Golding JR, Lee PN, et al. Penicillamine in rheumatoid disease: a long term study. Br Med J 1974; 1:180-3.
7. Dixon AJ, Davies J, Dormandy TL, et al. Synthetic D(-) penicillamine in rheumatoid arthritis: double blind controlled study of a high and low dose regime. Ann Rheum Dis 1975;34:416-21.
8. Multicentre Trial Group. Controlled trial of D-penicillamine in severe rheumatoid arthritis. Lancet 1973;1:275-80.
9. Crawhall JC, Scowen EF, Watts RWE. Effects of penicillamine on cystinuria. Br Med J 1963;1:588-90.
10. Winklemann RK, Kierland RR, Perry HO, et al. Management of scleroderma. Mayo Clin Proc 1971;46:128-34.
11. Weigert WM, Offermans H, Scherberick P. D-penicillamine - production and properties. Angew Chem Int Ed 1975;14:330-6.
12. Perrett D. The metabolism and pharmacology of D-penicillamine in man. J Rheumatol 1981;8(suppl 7):41-50.
13. Kyogoku K, Inoue K, Otake T, et al. Determination of D-penicillamine and its metabolites in blood and urine. Yakugaku Zasshi 1982;102:322-7.
14. 35S-D-penicillamine in man. Xenobiotica 1988;18:235-44.
15. Capell HA, Madhok R, Zoma A, et al. Is determination of sulfoxidation status a useful predictor of penicillamine toxicity in RA patients? Proceedings of the Third World Conference on Clinical Pharmacology and Therapeutics, Stockholm, July-August 1986, Abstract 658.
16. Herbert CM, Jayson MIV, Lindberg KA, et al. The action of D-penicillamine on collagen in scleroderma and osteoarthritis. Postgrad Med J 1974;50(suppl 2):27-30.
17. Nimni ME. Mechanisms of inhibition of collagen crosslinking by penicillamine. Proc R Soc Med 1977;70(suppl 3):65-72.
18. Vitto J. Biochemistry of the elastic fibers in normal connective tissues and its alternations in diseases. J Invest Dermatol 1979;72:1-10.
19. Katz R. Penicillamine-induced skin lesions: a possible example of human lathyrism. Arch Dermatol 1977; 95:196-8.
20. Beer WE, Cooke KB. Epidermolysis bullosa induced by penicillamine. Br J Dermatol 1967;79:123-5.
21. Greer KS, Askew FC, Richardson DR. Skin lesions induced by penicillamine: occurrence in a patient with hepatolenticular degeneration (Wilson's disease). Arch Dermatol 1976;112:1267-9.
22. Davis W. Wilson's disease and penicillamine-induced anetoderma. Arch Dermatol 1977;113:976.
23. Pass F, Goldfischer S, Sternlieb I. Elastosis perforans serpiginosa during penicillamine therapy for Wilson's disease. Arch Dermatol 1973;108:713-5.
24. Kirsch N, Hukill PB. Elastosis perforans serpiginosa induced by penicillamine. Arch Dermatol 1977;113:630-5.
25. Dalziel KL, Burge SM, Frith PA, et al. Elastic fibre damage induced by low-dose D-penicillamine. Br J Dermatol 1990;123:305-12.
26. Sternlieb I, Fisher M, Scheinberg IH. Penicillamineinduced skin lesions. J Rheumatol 1981;8(suppl 7): 149-54.
27. Shiokawa Y, Horiuchi Y, Honma M, et al. Clinical evaluation of D-penicillamine by multicentric double blind comparative study in chronic rheumatoid arthritis. Arthritis Rheum 1977;20:1464-72.
28. Situnayake RD, Grindulis KA, McConkey B. Long-term treatment of rheumatoid arthritis with sulfasalazine, gold and penicillamine: a comparison using life table methods. Ann Rheum Dis 1987;46:177-83.
29. Capell HA, Marabani M, Madhok R, et al. Degree and extent of response to sulfasalazine or penicillamine therapy for rheumatoid arthritis: results from a routine clinical environment over a two year period. Q J Med 1990; 75:335-44.
30. Samanta A, Roy S, Woods KL. A life table analysis of factors affecting continuation of therapy with D-penicillamine or intramuscular gold in rheumatoid arthritis: a 15 year study. Br J Rheumatol 1990;29(suppl 2):50.
31. Howard-Lock HE, Lock CJL, Mewa A, et al. D-Penicillamine: chemistry and clinical use in rheumatic disease. Semin Arthritis Rheum 1986;15:261-81.
32. Ayesh R, Mitchell SC, Waring RH, et al. Sodium aurothiomalate toxicity and sulfoxidation capacity in rheumatoid arthritis patients. Br J Rheumatol 1987; 26:197-202.
33. Stein HB, Ruedy J, Atkins CJ, et al. Penicillamine and other remittive agents in rheumatoid arthritis: comparisons and interactions. Clin Invest Med 1984;7:59-63.
34. Garlepp MJ, Dawkins RL, Christiansen FT. HLA antigens and acetylcholine receptor antibodies in penicillamine induced myasthenia gravis. Br Med J 1983;286:338-40.
35. Delamere JP, Jobson S, Mackintosh LP, et al. Penicillamine-induced myasthenia in rheumatoid arthritis: its clinical and genetic features. Ann Rheum Dis 1983; 42:500-4.
36. Stockman A, Zilko PJ, Major GA, et al. Genetic markers in rheumatoid arthritis: relationship to toxicity from D-penicillamine. J Rheumatol 1986;13:269-73.
37. Perrier P, Raffoux C, Thomas P, et al. HLA antigens and toxic reactions to sodium aurothiopropanol sulfonate and D-penicillamine in patients with rheumatoid arthritis. Ann Rheum Dis 1985;44:621-4.
38. Joyce DA. D-penicillamine. Baillères Clin Rheumatol 1990;4:553-74.
39. Taylor HG, Samanta A. Penicillamine in rheumatoid arthritis: a problem of toxicity. Drug Saf 1992;7:46-53.
40. Levy RS, Fisher M, Alter JN. Penicillamine: review and cutaneous manifestations. J Am Acad Dermatol 1983; 8:548-58.
41. Stein HB, Patterson AC, Offer RC, et al. Adverse effects of D-penicillamine in rheumatoid arthritis. Ann Intern Med 1980;92:24-9.
42. Ruocco V, de Angelis E, de Luca M, et al. Specific incorporation of penicillamine into the epidermis of mice: an autoradiographic study. Br J Dermatol 1983;108:441-4.
43. 3H]-D-penicillamine in mouse kidney: an autoradiographic study. Rheumatol Int 1984;4:183-6.
44. Wernick R, Merryman P, Jaffe I, et al. IgG and IgM rheumatoid factors in rheumatoid arthritis: quantitative response to penicillamine therapy and relationship to disease activity. Arthritis Rheum 1983;26:593-8.
45. Dixon JS, Pickup ME, Lower JR, et al. Discriminatory indices of response in patients with rheumatoid arthritis treated with D-penicillamine. Ann Rheum Dis 1980; 34:416-21.
46. Williams A, Scott DL, Greenwood A, et al. The clinical value of measuring immunoglobulins when assessing penicillamine therapy in rheumatoid arthritis. Clin Rheumatol 1980;7:347-53.
47. Ruocco V, de Luca M, Pisani M, et al. Pemphigus provoked by D-penicillamine: an experimental approach using in vitro tissue cultures. Dermatologica 1982;164:236-48.
48. Morioka S, Ogawa H. Herpetiform pemphigus-like skin lesions induced by D-penicillamine. J Dermatol (Tokyo) 1980;7:425-9.
49. McKeown MJ, Hall ND, Corvalan JRF. Defective monocyte accessory function due to surface sulfydryl (SH) oxidation in rheumatoid arthritis. Clin Exp Immunol 1984; 56:607-13.
50. Ristow SS, Starkey JR, Stanford DR, et al. Cell surface thiols, but not intracellular glutathione, are essential for cytolysis by a cloned murine natural killer cell line. Immunol Invest 1985;14:401-14.
51. Thorne KJI, Free J, Franks D. Role of sulfydryl groups in T-lymphocyte-mediated cytotoxicity. Clin Exp Immunol 1982;50:644-50.
52. Dawkins RL, Zilko PJ, Carrano J, et al. Immunobiology of D-penicillamine. J Rheumatol 1981;8(suppl 7):56-61.
53. Huskisson EC, Berry H. Some immunoglobulin changes in rheumatoid arthritis among patients receiving penicillamine and gold. Postgrad Med J 1974;50(suppl 2):59-61.
54. Epstein D, DeVilliers D, Jain S, et al. Reduction of immune complexes and immunoglobulins induced by D-penicillamine in primary biliary cirrhosis. N Engl J Med 1979;300:274-8.
55. Pisani M, Ruocco V. Drug-induced pemphigus. Clin Dermatol 1986;4:118-32.
56. Camus JP, Crouzet J, Bach JF, et al. Autoantibodies in D-penicillamine treated rheumatoid arthritis. Agents Actions 1976;6:351-4.
57. Jones E, Sobkowski WW, Murray SJ, et al. Concurrent pemphigus and myasthenia gravis as manifestations of penicillamine toxicity. J Am Acad Dermatol 1993; 28:655-6.
58. Degos T, Touraine R, Belaich S, et al. Pemphigus chez un malade traite par penicillamine pour malladie de Wilson. Bull Soc Fr Dermatol Syphiligr 1969;76:751-3.
59. Benveniste M, Crouzet J, Homberg JC, et al. Pemphigus induced by D-penicillamine in rheumatoid arthritis: study of 5 cases and systematic study of anti-intercellular substance antibodies of the skin in the course of treatment. Nouv Presse Med 1975;4:3125-8.
60. Hewitt J, Benveniste M, Lessana-Leibowitch M. Pemphigus induced by D-penicillamine [letter]. Br Med J 1975;3:371.
61. Marsden RA, Ryan TJ, Van Hegan RI, et al. Pemphigus foliaceus induced by penicillamine. Br Med J 1976; 4:1423-4.
62. Brenner S, Wolf R, Ruocco V. Drug induced pemphigus: I. a survey. Clin Dermatol 1993;11:501-5.
63. Ruocco V, Sacerdoti G. Pemphigus and bullous pemphigoid due to drugs. Int J Dermatol 1991;30:307-12.
64. Santa Cruz DJ, Prioleau PG, Marcus MD, et al. Pemphigus-like lesions induced by D-penicillamine. Am J Dermatopathol 1981;3:85-92.
65. Eisenberg E, Ballow M, Wolfe SH, et al. Pemphigus-like mucosal lesions: a side effect of penicillamine therapy. Oral Surg 1981;51:409-14.
66. Troy JL, Silvers DN, Grossman ME, et al. Penicillamine-associated pemphigus: Is it really pemphigus? J Am Acad Dermatol 1981;4:547-55.
67. DeJong MC, Doeglas HMG, Dijkstra JWE. Immunohistochemical findings in a patient with penicillamine pemphigus. Br J Dermatol 1980;102:333-7.
68. Korman NJ, Eyre RW, Zone J, et al. Drug induced pemphigus: autoantibodies directed against the pemphigus antigen complexes are present in penicillamine and captopril induced pemphigus. J Invest Dermatol 1991;96: 273-6.
69. Velthuis PJ, Hendrikse JC, Nefkens JJ. Combined features of pemphigus and pemphigoid induced by penicillamine. Br J Dermatol 1985;112:615-9.
70. Zone J, Ward J, Boyce E, et al. Penicillamine induced pemphigus. JAMA 1982;247:2705-7.
71. Rasmussen HB, Jepsen LV, Brandrup F. Penicillamine induced bullous pemphigoid with pemphigus-like antibodies. J Cutan Pathol 1989;16:154-7.
72. Marsden RA, Dawber RPR, Millard PR, et al. Herpetiform pemphigus induced by penicillamine. Br J Dermatol 1977;97:451-2.
73. Ho VC, Stein HB, Ongley RC, et al. Penicillamine induced pemphigus. J Rheumatol 1985;12:583-6.
74. Bauer-Vinassac D, Menkes CJ, Muller JY, et al. HLA system and penicillamine induced pemphigus in nine cases of rheumatoid arthritis. Scand J Rheumatol 1992; 21:17-9.
75. Brown MD, Dubin HV. Penicillamine-induced bullous pemphigoid-like eruption. Arch Dermatol 1987;123: 1119-20.
76. Pegum JS, Pembroke AC. Benign mucous membrane pemphigus associated with penicillamine treatment [letter]. Br Med J 1977;1:1473.
77. Lever LR, Wojnarowska F. Benign mucous membrane pemphigoid and penicillamine. Br J Dermatol 1985; 113(suppl 29):88-9.
78. Shuttleworth D, Graham Brown RAC. Cicatricial pemphigoid in a D-penicillamine treated patient with rheumatoid arthritis. Br J Dermatol 1985;113(suppl 29):89-90.
79. Shuttleworth D, Graham Brown RA, Hutchinson PE, et al. Cicatricial pemphigoid in D-penicillamine treated patients with rheumatoid arthritis: a report of three cases. Clin Exp Dermatol 1985;10:392-7.
80. Peyri J, Servitje O, Ribera M, et al. Cicatricial pemphigoid in a patient with rheumatoid arthritis treated with D-penicillamine [letter]. J Am Acad Dermatol 1986;14:681.
81. Marti-Huguet T, Quintana M, Cabiro I. Cicatricial pemphigoid associated with D-penicillamine treatment [letter]. Arch Ophthalmol 1989;107:1115.
82. Morioka S, Ogawa H. Herpetiform pemphigus-like skin lesions induced by D-penicillamine. J Dermatol (Tokyo) 1980;7:425-9.
83. Hay KD, Muller HK, Reade PC. D-Penicillamine-induced mucocutaneous lesions with features of pemphigus. Oral Surg Oral Med Oral Pathol 1978;45:385-95.
84. Trau H, Schewach-Millet M, Gold I, et al. Penicillamine-induced pemphigus. Arch Dermatol 1980;116:721-2.
85. Walton S, Keczkes K, Robinson AE. A case of penicil-lamine-induced pemphigus, successfully treated by plasma exchange. Clin Exp Dermatol 1987;12:275-6.
86. Blanken R, Doeglas HMG, De Jong MC, et al. Pemphigus-like eruption induced by d-penicillamine and captopril, in the same patient. Acta Derm Venereol (Stockh) 1988;68:456-7.
87. Trunnell TN, Adelman HM, Waisman M. Pemphigus-like eruption due to penicillamine. Cutis 1981;27:402-4.
88. Matkaluk RM, Bailin PL. Penicllamine-induced pemphigus foliaceus: a fatal outcome. Arch Dermatol 1981; 117:156-7.
89. Kohn SR. Fatal penicillamine-induced pemphigus foliaceus-like dermatosis [letter]. Arch Dermatol 1986;122:17.
90. Savill JS, Chia Y, Pusey CD. Minimal change nephropathy and pemphigus vulgaris associated with penicil-lamine treatment of rheumatoid arthritis. Clin Nephrol 1988;29:267-70.
91. Gibson LE, Dicken CH. Pemphigus erythematosus, primary biliary cirrhosis, and D-penicillamine: report of a case [letter]. J Am Acad Dermatol 1985;12:883-5.
92. Amerian ML, Ahmed AR. Pemphigus erythematosus. J Am Acad Dermatol 1984;10:215-22.
93. Scherak O, Kolarz G, Molubar K. Pemphigus erythematosus-like rash in a patient on penicillamine [letter]. Br Med J 1977;1:838.
94. Davies MG, Holt P. Pemphigus in a patient treated with penicillamine for generalized morphea. Arch Dermatol 1976;112:1308-9.
95. Sparrow GP. Penicillamine pemphigus and the nephrotic syndrome occurring simultaneously. Br J Dermatol 1978; 98:103-5.
96. Tan SG, Rowell NR. Pemphigus-like syndrome induced by D-penicillamine. Br J Dermatol 1976;95:99-100.
97. Kristensen JK, Wadskov S. Penicillamine-induced pemphigus foliaceus. Acta Derm Venereol (Stockh) 1977; 57:69-71.
98. From E, Frederiksen P. Pemphigus vulgaris following D-penicillamine. Dermatologica 1976;152:358-62.
99. Thorvalsden J. Two cases of penicillamine-induced pemphigus erythematosus. Dermatologica 1979;159:167-70.
100. Knezevic W, Mastaglia FL, Quintner J, et al. Guillain-Barre syndrome and pemphigus foliaceus associated with D-penicillamine therapy. Aust N Z J Med 1984; 14:50-2.
101. Fye KH, Tanenbaum L. Penicillamine-induced pemphigus vulgaris in psoriatic arthritis. J Rheumatol 1982; 9:331-2.
102. Livden JK, Naevdal A, Milde EJ. Pemphigus in rheumatoid arthritis treated with penicillamine. Scand J Rheumatol 1981;10:95-6.
103. Williemsen MJ, De Coninck AL, De Raeve LE, et al. Penicillamine-induced pemphigus erythematosus. Int J Dermatol 1990;29:193-7.
104. Hashimoto K, Singer K, Lazarus GS. Penicillamine-induced pemphigus:immunoglobulin from this patient induces plasminogen activator synthesis by human epidermal cells in culture. Arch Dermatol 1984;120:762-4.
105. Yung CW, Hambrick GW Jr. D-Penicillamine-induced pemphigus syndrome. J Am Acad Dermatol 1982;6:317-24.
106. Kennedy C, Hodge L, Sanderson KV. Skin changes caused by D-penicillamine treatment of arthritis: report of three cases with immunological findings. Clin Exp Dermatol 1978;3:107-16.
107. Godar JM, Norins AL. Vesicular lesions in a woman with progressive systemic sclerosis: penicillamine-induced intradermal vesicles. ArchDermatol 1992;128:977-8,980-1.
108. Lever WF. Pemphigus and pemphigoid. J Am Acad Dermatol 1979;1:2-31.
109. Rapoport R, Kozin F, Mackel S, et al. Cutaneous vascular immunofluorescence in rheumatoid arthritis. Am J Med 1980;68:325-31.
110. Wilkinson SM, Smith AG, Davis MJ, et al. Rheumatoid arthritis: an association with pemphigus foliaceous. Acta Derm Venereol (Stockh) 1992;72:289-91.
111. Matzner Y, Erlich HA, Brautbar C, et al. Identical HLA class II alleles predispose to drug triggered and idiopathic pemphigus vulgaris. Acta Derm Venereol (Stockh) 1995; 75:12-4.
112. Ruocco V, Pisani M. Induced pemphigus. Arch Dermatol Res 1982;274:123-40.
113. Unis ME, Pfau RG, Patel H, et al. Acquired form of epidermolysis bullosa without immunoreactants. J Am Acad Dermatol 1985;13:377-80.